Special Issue "Treatment of Neurological Movement Disorders"
A special issue of Healthcare (ISSN 2227-9032).
Deadline for manuscript submissions: closed (30 September 2014)
Dr. Gian Pal
Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA
Interests: parkinson’s disease; dystonia; atypical Parkinsonism; gait disorders; deep brain stimulation; genetics; surgical treatments
As the field of movement disorders continues to expand, the number of available treatment options also continues to grow. These include both pharmacologic and surgical interventions, such as deep brain stimulation (DBS). DBS has been approved by the Food and Drug Administration for use in advanced Parkinson’s disease, tremor, and dystonia. Studies have clearly established its efficacy for these approved indications which has led to the exploration of DBS for treatment of other movement disorders, including Atypical Parkinsonism and severe cases of Gilles de la Tourette syndrome. DBS is also being evaluated for treatment of psychiatric disorders and even cognitive disorders, many of which overlap with movement disorders. The outcome of these potential new indications hinges on the combination of appropriate diagnosis, surgical target selection, and patient candidacy—factors which remain to be fully defined. In this issue, we will explore how DBS has been used throughout movement disorders for both approved and non-approved indications, and provide insight into potential future uses of this surgical treatment.
Proposed article titles:
- DBS in treating advanced Parkinson’s disease with motor fluctuations and dyskinesia
- DBS in treating Parkinson’s disease: focus on moderate disease and quality of life outcomes
- DBS in treating drug-resistant features of Parkinson’s disease: where are we heading?
- DBS for other parkinsonian syndromes (atypical Parkinsonism)
- DBS in dystonia
- DBS in tremor
- DBS in Gilles de la Tourette syndrome
- Future directions: new technologies, new targets, new diseases
Dr. Gian Pal
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Healthcare is an international peer-reviewed Open Access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. For the first couple of issues the Article Processing Charge (APC) will be waived for well-prepared manuscripts. English correction and/or formatting fees of 250 CHF (Swiss Francs) will be charged in certain cases for those articles accepted for publication that require extensive additional formatting and/or English corrections.
- Parkinson’s disease
- Gilles de la Tourette syndrome
- Atypical parkinsonism
- Deep brain stimulation
Last update: 13 March 2014